NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Quanterix's Simoa SARS-CoV-2 N Protein Antigen Test.
NEW YORK — The US Food and Drug Administration on Tuesday granted Emergency Use Authorization for Quanterix's Simoa SARS-CoV-2 N Protein Antigen Test.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.